Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 5/2004

Content (14 Articles)

Original Article

Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023

Hans Minderman, Tracy A. Brooks, Kieran L. O’Loughlin, Iwao Ojima, Ralph J. Bernacki, Maria R. Baer

Original Article

Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

Mary Johansen, Thomas Zukowski, Paulo M. Hoff, Robert A. Newman, Dan Ni, Toni Hutto, James Abbruzzeese, Elmer Berghorn, Frederick Hausheer, Timothy Madden

Original Article

Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor

Francisco Chung, Liang-Chuan S. Wang, Philip Kestell, Bruce C. Baguley, Lai-Ming Ching

Original Article

Interactions of a herbal combination that inhibits growth of prostate cancer cells

Vinh Q. Chung, Martin Tattersall, H. T. Andrew Cheung

Original Article

Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis

Mikito Inokuchi, Hiroyuki Uetake, Yoshinori Shirota, Hiroyuki Yamada, Masayuki Tajima, Kenichi Sugihara

Original Article

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine

Keith T. Flaherty, James P. Stevenson, Maryann Redlinger, Kenneth M. Algazy, Bruce Giantonio, Peter J. O’Dwyer

Original Article

Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model

Kentaro Inoue, Hiraku Onishi, Yoshinori Kato, Taku Michiura, Koji Nakai, Mutsuya Sato, Keigo Yamamichi, Yoshiharu Machida, Yasushi Nakane

Original Article

Antimalarial dihydroartemisinin also inhibits angiogenesis

Huan-Huan Chen, Hui-Jun Zhou, Wei-Qin Wang, Guo-Dong Wu

Original Article

Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules

Zariana Nikolova, Bin Peng, Martine Hubert, Michael Seiberling, Urs Keller, Yu-Yun Ho, Horst Schran, Renaud Capdeville

Original Article

Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study

Sakkaraiappan Ramalingam, Tracy W. Dobbs, Avi I. Einzig, Slawomir Wojtowicz-Praga, Marianne Cascino, Phillip Bonomi, Chandra P. Belani

Original Article

Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population

Hui-Hua Hsiao, Ming-Yu Yang, Jan-Gowth Chang, Yi-Chang Liu, Ta-Chih Liu, Chao-Sung Chang, Tyen-Po Chen, Sheng-Fung Lin

Original Article

Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel

Evangelos Briasoulis, Vasilis Karavasilis, Eleftheria Tzamakou, Dimitra Rammou, Kali Soulti, Christina Piperidou, Nicholas Pavlidis

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine